Abstract:OBJECTIVE:To investigate the relationship between G1958A gene polymorphism of methylenetetrahydrofolate dehydrogenase (MTHFD) and occurrence of congenital heart disease (CHD) in North China.METHODS:One hundred and ninety-two CHD patients and their parents were included in this study as case group in Liaoning Province by birth defect registration cards, and 124 healthy subjects (age and gender matched) and their parents were simultaneously selected from the same geographic area as control. Their gene polymorphism of MTHFD G1958A locus was examined with PCR-RFLP, and serum folic acid and homocysteine (Hcy) levels were tested with radio-immunoassay and fluorescence polarization immunoassay (FPIA).RESULTS:There existed gene polymorphism at MTHFD G1958A locus in healthy subjects living in North China. The percentages of GG, GA, and AA genotype were 57.98%, 35.57%, and 6.45% respectively, and the A allele frequency was 24.23%, which was significantly different from Western population. No difference was observed when comparing genotype distribution and allele frequency between the case and control groups, so was the result from the comparison between genders. The A allele frequency of arterial septal defect patients' mothers (10.87%) was significantly lower than that of controls (28.15%) (P=0.014), with OR=0.31 (95% CI: 0.09-0.84), and no difference in the other subgroups. The percentage of at least one parent carrying A allele in arterial septal defect subgroup (43.48%) was significantly lower than that in controls (69.64%) (P=0.017), with OR=0.34 (95% CI: 0.12-0.92). The analysis of genetic transmission indicated that there was no transmission disequillibrium in CHD nuclear families. Their serum folic acid level was significantly higher than that of controls (P=0.000), and Hcy level of the former was higher than that of the latter with no statistical significance (P>0.05). Serum Hcy and folic acid levels of mothers with gene mutation were lower than those of mothers with no mutation.CONCLUSION:No significant difference of genotype distribution and allele frequency existed between CHD patients and healthy population. MTHFD G1958A mutation in parents (particularly in mother) can decrease the risk of arterial septal defect in offspring. The possible mechanism of protection might be mutation, which can increase MTHFD enzyme activity, folic acid metabolism and homocysteine remethylation, and decrease Hcy level.

Relationship of Maternal and Child Polymorphism in Methionine Synthetase and Methionine Synthase Reductase with Congenital Heart Disease

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Association of fetal congenital heart diseases with methylenetetrahydrofolate reductase gene polymorphisms

Association of maternal methionine synthase reductase gene polymorphisms with the risk of congenital heart disease in offspring: a hospital-based case-control study

Relationship Between Polymorphism of Methylenetetrahydrofolate Dehydrogenase and Congenital Heart Defect.

Relationship between MTHFR C677T Polymorphisms and Susceptibility of Digestive System Cancer and Coronary Heart Disease

Association Between the Polymorphism of Methylenetetrahydrofolate Reductase Gene C 677 T and Risks of Congenital Heart Disease : Meta-analysis of Case-control Study

Study on Maternal SNPs of MTHFR Gene and HCY Level Related to Congenital Heart Diseases

Parental Genetic Variants, Mthfr 677c>t and Mtrr 66a>g, Associated Differently with Fetal Congenital Heart Defect

Polymorphism of Methionine Synthase Gene in Nuclear Families of Congenital Heart Disease

Relationship Between the Polymorphisms of MTHFR and MTRR Gene and the Susceptibility of Delivering a Child with Down Syndrome

Association of MTR gene polymorphisms with the occurrence of non-syndromic congenital heart disease: a case–control study

Association Between Mthfr Polymorphisms and Congenital Heart Disease: A Meta-Analysis Based on 9,329 Cases and 15,076 Controls

Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease

Association of MTHFR C677T, MTHFR A1298C and MTRR A66G Polymorphisms with Birth Defects in Southern China

Maternal and Offspring Mthfr Gene C677t Polymorphism As Predictors of Congenital Atrial Septal Defect and Patent Ductus Arteriosus

Effect of parental 5, 10-methylenetetrahydrofolate dehydrogenase genotypes on offspring congenital heart defect risk

Methylenetetrahydrofolate Dehydrogenase G1958A Gene Polymorphism and Congenital Heart Defect Susceptibility

Relationship between risk factors during pregnancy,maternal MTHFR gene 677C→T,plasma Hcy levels and congenital heart disease in children

[Effects of Methionine Synthase Gene Variation in Parents on Occurence of Congenital Heart Disease in Offspring].

Meta-analysis of the Association Between 5,10-Methylenetetrahydrofolate Reductase C677T Polymorphisms and Congenital Heart Disease